Head-to-head · Cost-Efficiency Index
Care Bare Rx vs Curex
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Care Bare Rx
People consolidating several telehealth needs on one verified platform who are willing to commit to a 12-month plan to get the cheapest per-month rate.
Visit Care Bare RxCurex
People who want a low-cost first month, an oral option, and a verified pharmacy nationwide, and don't need a dose-by-dose price table before signing up.
Visit CurexThe verdict
Curex takes it, leading the Cost-Efficiency Index 81 to 80. A discounted first month ($49-$149) steps up to a 'starting at $199' ongoing rate — real, but not the flat, fully-disclosed price the headline implies, and California loses the injectable route entirely. Care Bare Rx still earns a B− — People consolidating several telehealth needs on one verified platform who are willing to commit to a 12-month plan to get the cheapest per-month rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Curex.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Care Bare Rx | Curex |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 81/100 |
| Semaglutide / mo | $199/mo month-to-month ($185/mo only on a 12-month prepay; the 3-month tier is dearer at $249/mo) | $199/mo Starting (first month $49) |
| Tirzepatide / mo | $299/mo month-to-month ($293/mo only on a 12-month prepay; the 3-month tier is dearer at $356/mo) | $199/mo Starting (first month $149) |
| Semaglutide / yr (modeled) | $2,388 | $2,388 |
| Tirzepatide / yr (modeled) | $3,588 | $2,388 |
| Coverage | All 50 states + Puerto Rico | All 50 states (California: oral tablet only, no injectable) |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #23 | #27 |
Care Bare Rx
80/100Where the value is
- LegitScript-certified and HIPAA-compliant, with both oral (Rybelsus, oral tirzepatide) and injectable options
- Real brand-name Ozempic available (from ~$705/mo) for anyone who specifically wants the on-label pen
- Coverage across all 50 states plus Puerto Rico — wider than most compounded telehealth options
The tradeoffs
- The 3-month plan is a real pricing trap — it costs more per month ($249 semaglutide / $356 tirzepatide) than either month-to-month or the 6-month plan
- The cheapest per-month rate requires a 12-month prepay commitment ($2,218 semaglutide / $3,518 tirzepatide total)
Curex
81/100Where the value is
- Discounted first month well below the ongoing rate — $49 for semaglutide, $149 for tirzepatide
- Nationwide enrollment (all 50 states) plus an oral/sublingual route as an alternative to injections
- 365-day money-back guarantee and a full refund if never prescribed
The tradeoffs
- The '$199/mo' figure is labeled 'Starting,' not flat — no dose-by-dose price table is published, so the real cost at a higher maintenance dose is unverified
- California residents cannot get the injectable route at all — oral tablets only, despite the 'all 50 states' enrollment claim
Regulatory note: the FDA issued a warning letter to Curex in September 2025. We still list and link to Curex; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.